From Clinical Question to Defensible Inference: A Decision Framework for Integrated Gut Microbiome–Metabolome Studies
References
- KNIGHT R., VRBANAC A., TAYLOR BC., AKSENOV A., CALLEWAERT C., DEBELIUS J., et al. Best practices for analysing microbiomes. Nat Rev Microbiol. 2018;16(7):410–22.
- LLOYD-PRICE J., ARZE C., ANANTHAKRISHNAN AN., SCHIRMER M., AVILA-PACHECO J., POON TW., et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature. 2019;569(7758):655–62.
- KRAUTKRAMER KA., FAN J., BÄCKHED F. Gut microbial metabolites as multi-kingdom intermediates. Nat Rev Microbiol. 2021;19(2):77–94.
- FRANZOSA EA., SIROTA-MADI A., AVILA-PACHECO J., FORNELOS N., HAISER HJ., REINKER S., et al. Gut microbiome structure and metabolic activity in inflammatory bowel disease. Nat Microbiol. 2019;4(2):293–305.
- COSTEA PI., ZELLER G., SUNAGAWA S., PELLETIER E., ALBERTI A., LEVENEZ F., et al. Towards standards for human fecal sample processing in metagenomic studies. Nat Biotechnol. 2017;35(11):1069–76.
- SINHA R., ABU-ALI G., VOGTMANN E., FODOR AA., REN B., AMIR A., et al. Assessment of variation in microbial community amplicon sequencing by the Microbiome Quality Control (MBQC) project consortium. Nat Biotechnol. 2017;35(11):1077–86.
- GLOOR GB., MACKLAIM JM., PAWLOWSKY-GLAHN V., EGOZCUE JJ. Microbiome datasets are compositional: and this is not optional. Front Microbiol. 2017;8:2224.
- MIRZAYI C., RENSON A., ZOHRA F., ELSAFOURY S., GEISTLINGER L., KASSELMAN LJ., et al. Reporting guidelines for human microbiome research: the STORMS checklist. Nat Med. 2021;27(11):1885–92.
- MULLER E., BAMBERGER T., BORENSTEIN E. Navigating multi-omic integration methods for human microbiome research. Nat Microbiol. 2026;11(5):1153–67.
- QUINCE C., WALKER AW., SIMPSON JT., LOMAN NJ., SEGATA N. Shotgun metagenomics, from sampling to analysis. Nat Biotechnol. 2017;35(9):833–44.
- DONALDSON GP., LEE SM., MAZMANIAN SK. Gut biogeography of the bacterial microbiota. Nat Rev Microbiol. 2016;14(1):20–32.
- VOGTMANN E., CHEN J., AMIR A., SHI J., ABNET CC., NELSON H., et al. Comparison of Collection Methods for Fecal Samples in Microbiome Studies. Am J Epidemiol. 2017;185(2):115–23.
- MCHARDY IH., GOUDARZI M., TONG M., RUEGGER PM., SCHWAGER E., WEGER JR., et al. Integrative analysis of the microbiome and metabolome of the human intestinal mucosal surface reveals exquisite inter-relationships. Microbiome. 2013;1(1):17.
- GRATTON J., PHETCHARABURANIN J., MULLISH BH., WILLIAMS HR., THURSZ M., NICHOLSON JK., et al. Optimized Sample Handling Strategy for Metabolic Profiling of Human Feces. Anal Chem. 2016;88(9):4661–8.
- LAGIER JC., HUGON P., KHELAIFIA S., FOURNIER PE., LA SCOLA B., RAOULT D. The rebirth of culture in microbiology through the example of culturomics to study human gut microbiota. Clin Microbiol Rev. 2015;28(1):237–64.
- BUSTIN SA., BENES V., GARSON JA., HELLEMANS J., HUGGETT J., KUBISTA M., et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009;55(4):611–22.
- CALLAHAN BJ., MCMURDIE PJ., ROSEN MJ., HAN AW., JOHNSON AJ., HOLMES SP. DADA2: High-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13(7):581–3.
- DOUGLAS GM., MAFFEI VJ., ZANEVELD JR., YURGEL SN., BROWN JR., TAYLOR CM., et al. PICRUSt2 for prediction of metagenome functions. Nat Biotechnol. 2020;38(6):685–8.
- LIU YX., QIN Y., CHEN T., LU M., QIAN X., GUO X., et al. A practical guide to amplicon and metagenomic analysis of microbiome data. Protein Cell. 2021;12(5):315–30.
- HILLMANN B., AL-GHALITH GA., SHIELDS-CUTLER RR., ZHU Q., GOHL DM., BECKMAN KB., et al. Evaluating the Information Content of Shallow Shotgun Metagenomics. mSystems. 2018;3(6).
- VANDEPUTTE D., KATHAGEN G., D'HOE K., VIEIRA-SILVA S., VALLES-COLOMER M., SABINO J., et al. Quantitative microbiome profiling links gut community variation to microbial load. Nature. 2017;551(7681):507–11.
- ALSEEKH S., AHARONI A., BROTMAN Y., CONTREPOIS K., D'AURIA J., EWALD J., et al. Mass spectrometry-based metabolomics: a guide for annotation, quantification and best reporting practices. Nat Methods. 2021;18(7):747–56.
- BROADHURST D., GOODACRE R., REINKE SN., KULIGOWSKI J., WILSON ID., LEWIS MR., et al. Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studies. Metabolomics. 2018;14(6):72.
- SUMNER LW., AMBERG A., BARRETT D., BEALE MH., BEGER R., DAYKIN CA., et al. Proposed minimum reporting standards for chemical analysis: Chemical Analysis Working Group (CAWG), Metabolomics Standards Initiative (MSI). Metabolomics. 2007;3(3):211–21.
- AGUS A., CLÉMENT K., SOKOL H. Gut microbiota-derived metabolites as central regulators in metabolic disorders. Gut. 2021;70(6):1174–82.
- ZIERER J., JACKSON MA., KASTENMÜLLER G., MANGINO M., LONG T., TELENTI A., et al. The fecal metabolome as a functional readout of the gut microbiome. Nat Genet. 2018;50(6):790–5.
- WANG Z., KLIPFELL E., BENNETT BJ., KOETH R., LEVISON BS., DUGAR B., et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472(7341):57–63.
- TANG WH., WANG Z., LEVISON BS., KOETH RA., BRITT EB., FU X., et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013;368(17):1575–84.
- NEARING JT., DOUGLAS GM., HAYES MG., MACDONALD J., DESAI DK., ALLWARD N., et al. Microbiome differential abundance methods produce different results across 38 datasets. Nat Commun. 2022;13(1):342.
- MALLICK H., RAHNAVARD A., MCIVER LJ., MA S., ZHANG Y., NGUYEN LH., et al. Multivariable association discovery in population-scale meta-omics studies. PLoS Comput Biol. 2021;17(11):e1009442.
- ROHART F., GAUTIER B., SINGH A., LÊ CAO KA. mixOmics: an R package for omics feature selection and multiple data integration. PLoS Comput Biol. 2017;13(11):e1005752.
- VARMA S., SIMON R. Bias in error estimation when using cross-validation for model selection. BMC Bioinformatics. 2006;7:91.
- DO KT., WAHL S., RAFFLER J., MOLNOS S., LAIMIGHOFER M., ADAMSKI J., et al. Characterization of missing values in untargeted MS-based metabolomics data and evaluation of missing data handling strategies. Metabolomics. 2018;14(10):128.
- LIN H., PEDDADA SD. Analysis of compositions of microbiomes with bias correction. Nat Commun. 2020;11(1):3514.
- LÊ CAO KA., ROSSOUW D., ROBERT-GRANIÉ C., BESSE P. A sparse PLS for variable selection when integrating omics data. Stat Appl Genet Mol Biol. 2008;7(1):Article 35.
- ARGELAGUET R., VELTEN B., ARNOL D., DIETRICH S., ZENZ T., MARIONI JC., et al. Multi-Omics Factor Analysis: a framework for unsupervised integration of multi-omics data sets. Mol Syst Biol. 2018;14(6):e8124.
- SINGH A., SHANNON CP., GAUTIER B., ROHART F., VACHER M., TEBBUTT SJ., et al. DIABLO: an integrative approach for identifying key molecular drivers from multi-omics assays. Bioinformatics. 2019;35(17):3055–62.
- LANGFELDER P., HORVATH S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.
- MORTON JT., AKSENOV AA., NOTHIAS LF., FOULDS JR., QUINN RA., BADRI MH., et al. Learning representations of microbe-metabolite interactions. Nat Methods. 2019;16(12):1306–14.
- RILEY RD., SNELL KIE., ENSOR J., BURKE DL., HARRELL FE Jr., MOONS KGM., et al. Minimum sample size for developing a multivariable prediction model: Part II – binary and time-to-event outcomes. Stat Med. 2019;38(7):1276–96.
- COLLINS GS., MOONS KGM., DHIMAN P., RILEY RD., BEAM AL., VAN CALSTER B., et al. TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ. 2024;385:e078378.
- MOONS KGM., DAMEN JAA., KAUL T., HOOFT L., ANDAUR NAVARRO CL., DHIMAN P., et al. PROBAST+AI: an updated quality, risk of bias, and applicability assessment tool for prediction models using regression or artificial intelligence methods. BMJ. 2025;388:e082505.
- NING L., ZHOU YL., SUN H., ZHANG Y., SHEN C., WANG Z., et al. Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohorts. Nat Commun. 2023;14:7135.
- LOUCA S., POLZ MF., MAZEL F., ALBRIGHT MBN., HUBER JA., O'CONNOR MI., et al. Function and functional redundancy in microbial systems. Nat Ecol Evol. 2018;2(6):936–43.
- VUJKOVIC-CVIJIN I., SKLAR J., JIANG L., NATARAJAN L., KNIGHT R., BELKAID Y. Host variables confound gut microbiota studies of human disease. Nature. 2020;587(7834):448–54.
- GREENLAND S., PEARL J., ROBINS JM. Causal diagrams for epidemiologic research. Epidemiology. 1999;10(1):37–48.
- KARTIOSUO N., NEVALAINEN J., RAITAKARI O., PAHKALA K., AURANEN K. Hypothesis-driven mediation analysis for compositional data: an application to gut microbiome. Biostat Epidemiol. 2024;8(1):e2360375.
- HIERGEIST A., REISCHL U., GESSNER A. Multicenter quality assessment of 16S ribosomal DNA sequencing for microbiome analyses reveals high inter-center variability. Int J Med Microbiol. 2016;306(5):334–42.
- PEPE MS., ETZIONI R., FENG Z., POTTER JD., THOMPSON ML., THORNQUIST M., et al. Phases of biomarker development for early detection of cancer. J Natl Cancer Inst. 2001;93(14):1054–61.
- KARCZEWSKI KJ., SNYDER MP. Integrative omics for health and disease. Nat Rev Genet. 2018;19(5):299–310.
DOI: https://doi.org/10.2478/rjim-2026-0022 | Journal eISSN: 2501-062X (formerly 1220-4749) | Journal ISSN: 1220-4749
Language: English, Romanian
Submitted on: Jul 30, 2026
Published on: Oct 22, 2026
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2026 Monica Manciulea Profir, Ruxandra F. Ionescu, Oana A. Popescu Roşu, Alin Constantin Stancu, Ioana Cucu, Sanda Maria Cretoiu, Luciana Alexandra Pavelescu, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.